ChinaBio™2026聚焦初创企业大赛赞助商
Pfizer
2026年获胜者
祝贺NeuroVanda Therapeutics在ChinaBio™ 2026聚焦初创企业大赛环节中获胜
基于对疾病生物学的深刻洞察，NeuroVanda专注于开发针对神经退行性疾病最关键驱动因素的变革性口服疗法。该公司已建立了专有的靶向蛋白降解平台，利用一种差异化的E3连接酶，在清除聚集蛋白方面具有卓越的选择性和效率。
感谢辉瑞公司再次赞助今年的比赛，也感谢所有其他入围者和参赛者。
What to expect
被选中的公司将有机会进行6分钟的推介，并参与现场反馈环节，届时将有来自顶级投资者、制药交易专家和生物技术KOL组成的评审团对推介进行评估，并在现场选出获胜者。
* 大会全程英文，现场不提供同传或者翻译服务
您将获得
- 吸引参会嘉宾的视线
- 一张大会免费门票，可以通过partneringONE™邀请投资者和其他参会者进行一对一会议。
- 获胜者 — 由评委选出，免费注册参加未来EBD的活动。
费用
- 路演费用: $195.00
* 必须满足条件才能享受这一价格。
条件:
- 三年内注册的公司，或者在公司内部孵化不超过三年的新项目
- 开发新的治疗解决方案、技术和数字平台
- 累计融资不超过1000万美元
- 员工人数少于20人的公司
2026 路演入围企业
Larry Cai
Board Member
Defand Tx
Startup Spotlight Boosted Visibility and Inbound Interest
"I believe participating in the Startup Spotlight gave Defand Tx an opportunity to showcase its platform technology and asset in development to a wider audience, which in turn generated more inbound inquiries afterwards."
Kevin Maskell
Bioarchitech
Startup Spotlight Victory Unlocks New Investor and Pharma Partnerships at ChinaBio® Partnering Forum
“The ChinaBio® Partnering Forum Startup Spotlight competition significantly raised our visibility with both investors and pharma partners. The calibre and diversity of the entries were outstanding. Winning the competition and having our social media post widely shared within our field led to meaningful follow-up and new opportunities.”
Lin Ong
COO
Medicovestor Inc
Startup Spotlight: The Direct Path to Genuine Investor Interest and Partnership Opportunities"
“Pitching at the ChinaBio® Partnering Forum Startup Spotlight was an incredible experience — it put us in front of exactly the right people. The interest we received after the session was immediate and genuine, with several investors and partners reaching out for follow-ups.”
